Mode
Text Size
Log in / Sign up
N/A Completed N=299 Randomized Single-blind Treatment

Implementing mHealth for Schizophrenia in Community Mental Health Settings

Source: ClinicalTrials.gov NCT04147897 ↗
Enrolled (actual)
299
Serious AEs
0.0%
Results posted
Nov 2025
Primary outcomePrimary: Patient Health Questionnaire (PHQ)-9 — 11.6; 10.7; 9.6; 10.2 Scores on scale — p=.06

Summary

Randomized control trial examining two mHealth intervention strategies.

Outcome Measures

OutcomeResultp-value
PRIMARY
Patient Health Questionnaire (PHQ)-9
11.6; 10.7; 9.6; 10.2; 9.3; 9.4 .06
PRIMARY
Generalized Anxiety Disorder-7 (GAD-7)
9.3; 9; 7.6; 7.9; 7.9; 7.6 0.37
PRIMARY
Insomnia Severity Index (ISI)
12.4; 12.4; 11.4; 11.9; 12.6; 11.1 .619
PRIMARY
Green Paranoid Thoughts Scale- Part B
31.8; 32.5; 31.6; 30.4; 32.4; 30.1 .32
PRIMARY
Symptom Check List (SCL-9)
13.7; 13; 11.2; 11.7; 10.7; 11.3 .31
PRIMARY
Hamilton Program for Schizophrenia Voices Questionnaire (HPSVQ)
14.3; 13.8; 13.6; 12.5; 13.0; 11.5 .63
PRIMARY
Illness Management and Recovery Scales (IMRS)
49.7; 49.8; 51.0; 50.7; 50.4; 51.2 0.67

Eligibility Criteria

All participants need to be receiving clinical care at participating clinics who have partnered with the research team for this study.

Inclusion:

  • Chart diagnosis of SSD (i.e., schizophrenia, schizoaffective disorder, schizotypal disorder, delusional disorder, or schizophreniform disorder;
  • 18 years or older;
  • English-speaking;
  • Own a smartphone that can support FOCUS and active data plan.

Exclusion:

  • Used FOCUS in the past;
  • Plan to move or discontinue services at participating clinics in the upcoming 6 months.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04147897). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search